What every physician should know about polycystic ovary syndrome

Dermatologic Therapy

Volumn 21, Issue 5, 2008, Pages 354-361

  Rosenfield, Robert L ^a,b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Acne; Hirsutism; Insulin resistance; Menstrual irregularity; Pattern alopecia

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; DESOGESTREL; DROSPIRENONE; EFLORNITHINE; ETYNODIOL DIACETATE; FINASTERIDE; GLUCOCORTICOID; GONADORELIN AGONIST; INSULIN; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; SPIRONOLACTONE;

CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ENDOCRINOLOGY; FERRIMAN GALLWEY HIRSUTISM; HIRSUTISM; HUMAN; HYPERANDROGENISM; LIVER TOXICITY; MENSTRUAL IRREGULARITY; METABOLIC DISORDER; MONOTHERAPY; OBESITY; OVARY POLYCYSTIC DISEASE; PREGNANCY; REVIEW; RISK FACTOR; SCORING SYSTEM; SCREENING TEST; TESTOSTERONE BLOOD LEVEL;

FEMALE; HIRSUTISM; HUMANS; POLYCYSTIC OVARY SYNDROME; RISK FACTORS;

EID: 53349118250     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2008.00217.x     Document Type: Review

References (27)

1. Buggs C, Rosenfield RL. Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am 2005:34:677 705.
2. Ehrmann DA. Medical progress: polycystic ovary syndrome. N Engl J Med 2004:352:1223 1236.
3. Martin KA, Chang RJ, Ehrmann DA, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrin Metab 2008:93:1105 1120.
4. Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients. Am J Obstet Gynecol 1986:155:531 543.
5. Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1987:1:235 245.
6. Di Carlo C, Shoham Z, MacDougall J, Patel A, Hall ML, Jacobs HS. Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea. Fertil Steril 1992:57:314 319.
7. Schachter M, Shoham Z. Amenorrhea during the reproductive years-is it safe? Fertil Steril 1994:62:1 16.
8. Shapiro J. Clinical practice. Hair loss in women [Comment in: N Engl J Med2008 Jan 31;358(5):533; author reply 533]. N Engl J Med 2007:357:1620 1630
9. Rosenfield RL. Polycystic ovary syndrome and insulin-resistant hyperinsulinemia. J Am Acad Dermatol, 2001:45:S095 S104.
10. Rosenfield RL. Clinical practice. Hirsutism [Comment in: N Engl J Med2006 Apr 6;354(14):1533-5; author reply 1533-5 ]. N Engl J Med 2005:353:2578 2588.
11. Lowe P, Kovacs G, Howlett D. Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia. Aust N Z J Obstet Gynaecol 2005:45:17 19.
12. Rosenfield RL. Identifying children at risk of polycystic ovary syndrome. J Clin Endocrinol Metab 2007:92:787 796.
13. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology and management. Am J Obstet Gynecol 1981:140:815 830.
14. Escobar-Morreale HF, Sanchon R, San Millan JL. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 2008:93:527 533.
15. Fegan PG, Sandeman DD, Krone N, et al. Cushing's syndrome in women with polycystic ovaries and hyperandrogenism. Nat Clin Pract Endocrinol Metab 2007:3:778 783.
16. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006:91:2 6.
17. Futterweit W, Ryan GL. A patient's guide to PCOS. New York:Henry Holt, 2006.
18. Arowojolu AO, Gallo MF, Lopez LM. Grimes DA, Garner SE. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2007:CD004425.
19. Giltay EJ, Gooren LJ. Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab 2000:85:2913 2921.
20. Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. Glucose intolerance in polycystic ovary syndrome. A position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007:92:4546 4556.
21. De Leo V, la Marca A, Petraglia F. Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev 2003:24:633 667.
22. Barbieri RL. Metformin for the treatment of polycystic ovary syndrome. Obstet Gynecol 2003:101:785 793.
23. Nestler JE. Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med 2008:358:47 54.
24. Ehrmann D, Cavaghan M, Imperial J, Sturis J, Rosenfield R, Polonsky K. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997:82:524 530.
25. Tan S, Hahn S, Benson S, et al. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance. Eur J Endocrinol 2007:157:669 676.
26. Gambineri A, Patton L, Vaccina A, et al. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. J Clin Endocrinol Metab 2006:91:3970 3980.
27. Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007:356:551 566.